Therapies for Stroke
- Home
- Therapies for Stroke
Therapies for Stroke – Regenerative & Cellular Approaches at RCERT
Stroke remains one of the leading causes of disability and death globally, including in Malaysia and Southeast Asia. While conventional treatments like thrombolysis and rehabilitation have helped many patients, regenerative medicine and cell-based therapies are now showing promise in restoring brain function and improving recovery outcomes after a stroke.
At RCERT (Regional Cell Research & Therapy Centre), we explore advanced therapies that go beyond traditional care — offering hope for stroke survivors through cell therapy, mitochondria-based repair, exosome treatment, and integrative recovery protocols.
🧠 What Is a Stroke?
A stroke occurs when the blood supply to a part of the brain is interrupted or reduced, depriving brain tissue of oxygen and nutrients. Within minutes, brain cells begin to die.
There are two main types:
-
Ischemic Stroke: Caused by blocked arteries (most common)
-
Hemorrhagic Stroke: Caused by bleeding in the brain
Common consequences of stroke include:
-
Paralysis or weakness (often on one side of the body)
-
Difficulty speaking or understanding
-
Loss of memory and cognitive function
-
Emotional instability and depression
🩺 Conventional Stroke Treatments
Standard medical care focuses on:
-
Thrombolysis (clot-busting drugs)
-
Mechanical thrombectomy
-
Medication to control blood pressure, cholesterol, or prevent clots
-
Physical and Occupational Therapy
-
Speech and Cognitive Rehabilitation
While these approaches are critical during the acute phase, they often offer limited recovery for brain damage once the critical window passes.
🌱 Regenerative Medicine: A New Hope for Stroke Recovery
At RCERT, we integrate cutting-edge regenerative therapies that aim to repair damaged neural tissue, restore function, and enhance quality of life. Our therapies are focused on cellular regeneration, neuroprotection, and inflammation control.
✅ RCERT’s Advanced Therapies for Stroke
1. Mesenchymal Stem Cell (MSC) Therapy
MSC therapy is one of the most researched forms of regenerative stroke therapy.
-
Source: MSCs are collected from bone marrow, umbilical cord, or adipose tissue.
-
Mechanism: MSCs do not directly replace neurons but release neuroprotective factors, promote angiogenesis (new blood vessels), and reduce inflammation in the brain.
-
Clinical Benefit: Improved motor function, speech recovery, memory, and cognitive processing.
RCERT offers GMP-grade MSC therapy derived and processed under safe clinical conditions in our Cell Processing Laboratory.
2. Exosome Therapy
Exosomes are small vesicles secreted by stem cells. They carry growth factors, mRNA, microRNA, and proteins that can modulate inflammation and support cell repair.
-
Cross the blood-brain barrier more easily than cells
-
Promote neuronal regeneration
-
Reduce secondary inflammation after a stroke
-
May enhance neuroplasticity and rehabilitation outcomes
RCERT uses exosomes in combination with stem cell therapy or as a standalone injectable or IV therapy.
3. Mitochondria Therapy
Stroke often leads to mitochondrial dysfunction in brain tissue, which impairs energy production and accelerates neuronal death.
RCERT’s mitochondria therapy aims to:
-
Restore cellular energy (ATP)
-
Protect neurons from oxidative stress
-
Improve metabolic recovery in damaged brain cells
This therapy is especially promising when combined with MSCs and exosomes, enhancing the overall healing cascade.
4. Hyperbaric Oxygen Therapy (Optional Add-on)
Though not a cell therapy, hyperbaric oxygen therapy (HBOT) is often used to support recovery post-stroke.
-
Increases oxygen delivery to damaged brain areas
-
Reduces edema and supports angiogenesis
-
May stimulate neural stem cells
RCERT partners with external wellness and rehabilitation centers to offer this therapy as part of an integrated recovery plan.
👨⚕️ Who Is Eligible for RCERT Stroke Therapies?
Our therapies may benefit:
-
Stroke survivors with lingering disabilities
-
Patients beyond the acute treatment window (1–6 months or longer)
-
Individuals who have plateaued with conventional rehab
-
Those seeking non-invasive regenerative options
-
High-risk patients looking for preventive neuroprotection
Each patient undergoes a thorough clinical evaluation, including neurological exams, imaging review, and lab tests, to ensure safety and customize therapy.
📈 Clinical Outcomes & Global Evidence
Studies have shown that regenerative stroke therapies, particularly MSCs and exosomes, can lead to:
-
Enhanced motor recovery (e.g., walking, hand use)
-
Improved speech and language function
-
Better emotional regulation and mood
-
Reduced dependence on caregivers
-
Slower progression of vascular cognitive impairment
At RCERT, we continue to collaborate with academic institutions like UNIMAS and research leaders like Zhongrong Cell Technology Center (China) to stay at the forefront of clinical evidence and cell innovation.
🛡️ Safety and Side Effects
All RCERT regenerative therapies are conducted under clinical and ethical oversight. Side effects are minimal and typically include:
-
Mild fever or fatigue after infusion
-
Transient soreness at injection site
-
Rare allergic or immune reactions (monitored on-site)
These treatments are designed to support natural healing without suppressing the immune system or causing systemic side effects common in pharmaceuticals.
🤝 Integrating Rehabilitation & Regenerative Medicine
We emphasize a multidisciplinary approach for stroke recovery. In addition to cell therapies, we coordinate with physiotherapists, neurologists, and speech therapists to:
-
Reinforce neuroplasticity
-
Optimize therapy outcomes
-
Track patient improvement via clinical scales
This integration ensures that patients don’t just get treatment — they get real, functional recovery.
📍 Why Choose RCERT for Stroke Recovery?
-
✅ State-of-the-art GMP Cell Processing Laboratory
-
✅ Clinical-grade MSC, Exosome, and Mitochondria therapies
-
✅ Customized, science-backed therapy plans
-
✅ In partnership with UNIMAS and Zhongrong China
-
✅ Patient-centered care and long-term follow-up
📝 Conclusion
Stroke recovery doesn’t end at the hospital. With RCERT’s advanced therapies — including MSC therapy, exosomes, and mitochondria therapy — stroke survivors now have access to regenerative solutions that go beyond traditional care.
We are committed to helping patients regain independence, restore brain function, and improve their overall quality of life.
📞 Interested in stroke therapy at RCERT?
Contact our team today to schedule a consultation.